Table 2.
Types of initial immunosuppression used after kidney transplantation in the group of patients, relating to the expression of indoleamine 2,3-dioxygenase (IDO1) in tubules. Specific quantities and percentages of positive and negative cases concerning a particular factor are presented.
| Initial Immunosuppression | IDO1 Expression in Tubules IDO1(+) Positive n = 76 | IDO1 Expression in Tubules IDO1(−) Negative n = 45 | p |
|---|---|---|---|
| Tacrolimus | 53 (70%) | 32 (71%) | 0.87 |
| Cyclosporin | 23 (30%) | 13 (29%) | 0.81 |
| MMF/MPA * | 76 (100%) | 45 (100%) | NS *** |
| Azathioprine | 2 (2.6%) | 0 (0%) | NS |
| Anti-CD25 ** therapy | 1 (1.3%) | 1 (2.2%) | 0.7 |
* Mycophenolate Mofetil or Mycophenolic Acid. ** Interleukin-2 receptor alpha chain. *** Not significant.